Glatiramer Market, Global Outlook and Forecast 2022-2028

February 2022 | 74 pages | ID: G4348CC11D08EN
Market Monitor Global

Abstracts

Glatiramer is an immunomodulator medication currently used to treat multiple sclerosis.

This report contains market size and forecasts of Glatiramer in global, including the following market information:

Global Glatiramer Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global Glatiramer Market Sales, 2017-2022, 2023-2028, (K Units)

Global top five Glatiramer companies in 2021 (%)

The global Glatiramer market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Brand Medicine Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Glatiramer include Teva, NATCO Pharma, Mylan, Novartis and HYBIO, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Glatiramer manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Glatiramer Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Glatiramer Market Segment Percentages, by Type, 2021 (%)

• Brand Medicine
• Generic Drug

Global Glatiramer Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Glatiramer Market Segment Percentages, by Application, 2021 (%)

• Hospital
• Pharmacy
• Other

Global Glatiramer Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Glatiramer Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Glatiramer revenues in global market, 2017-2022 (Estimated), ($ millions)

Key companies Glatiramer revenues share in global market, 2021 (%)

Key companies Glatiramer sales in global market, 2017-2022 (Estimated), (K Units)

Key companies Glatiramer sales share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Teva
• NATCO Pharma
• Mylan
• Novartis
• HYBIO

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Glatiramer Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Glatiramer Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL GLATIRAMER OVERALL MARKET SIZE

2.1 Global Glatiramer Market Size: 2021 VS 2028
2.2 Global Glatiramer Revenue, Prospects & Forecasts: 2017-2028
2.3 Global Glatiramer Sales: 2017-2028

3 COMPANY LANDSCAPE

3.1 Top Glatiramer Players in Global Market
3.2 Top Global Glatiramer Companies Ranked by Revenue
3.3 Global Glatiramer Revenue by Companies
3.4 Global Glatiramer Sales by Companies
3.5 Global Glatiramer Price by Manufacturer (2017-2022)
3.6 Top 3 and Top 5 Glatiramer Companies in Global Market, by Revenue in 2021
3.7 Global Manufacturers Glatiramer Product Type
3.8 Tier 1, Tier 2 and Tier 3 Glatiramer Players in Global Market
  3.8.1 List of Global Tier 1 Glatiramer Companies
  3.8.2 List of Global Tier 2 and Tier 3 Glatiramer Companies

4 SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 By Type - Global Glatiramer Market Size Markets, 2021 & 2028
  4.1.2 Brand Medicine
  4.1.3 Generic Drug
4.2 By Type - Global Glatiramer Revenue & Forecasts
  4.2.1 By Type - Global Glatiramer Revenue, 2017-2022
  4.2.2 By Type - Global Glatiramer Revenue, 2023-2028
  4.2.3 By Type - Global Glatiramer Revenue Market Share, 2017-2028
4.3 By Type - Global Glatiramer Sales & Forecasts
  4.3.1 By Type - Global Glatiramer Sales, 2017-2022
  4.3.2 By Type - Global Glatiramer Sales, 2023-2028
  4.3.3 By Type - Global Glatiramer Sales Market Share, 2017-2028
4.4 By Type - Global Glatiramer Price (Manufacturers Selling Prices), 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Glatiramer Market Size, 2021 & 2028
  5.1.2 Hospital
  5.1.3 Pharmacy
  5.1.4 Other
5.2 By Application - Global Glatiramer Revenue & Forecasts
  5.2.1 By Application - Global Glatiramer Revenue, 2017-2022
  5.2.2 By Application - Global Glatiramer Revenue, 2023-2028
  5.2.3 By Application - Global Glatiramer Revenue Market Share, 2017-2028
5.3 By Application - Global Glatiramer Sales & Forecasts
  5.3.1 By Application - Global Glatiramer Sales, 2017-2022
  5.3.2 By Application - Global Glatiramer Sales, 2023-2028
  5.3.3 By Application - Global Glatiramer Sales Market Share, 2017-2028
5.4 By Application - Global Glatiramer Price (Manufacturers Selling Prices), 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Glatiramer Market Size, 2021 & 2028
6.2 By Region - Global Glatiramer Revenue & Forecasts
  6.2.1 By Region - Global Glatiramer Revenue, 2017-2022
  6.2.2 By Region - Global Glatiramer Revenue, 2023-2028
  6.2.3 By Region - Global Glatiramer Revenue Market Share, 2017-2028
6.3 By Region - Global Glatiramer Sales & Forecasts
  6.3.1 By Region - Global Glatiramer Sales, 2017-2022
  6.3.2 By Region - Global Glatiramer Sales, 2023-2028
  6.3.3 By Region - Global Glatiramer Sales Market Share, 2017-2028
6.4 North America
  6.4.1 By Country - North America Glatiramer Revenue, 2017-2028
  6.4.2 By Country - North America Glatiramer Sales, 2017-2028
  6.4.3 US Glatiramer Market Size, 2017-2028
  6.4.4 Canada Glatiramer Market Size, 2017-2028
  6.4.5 Mexico Glatiramer Market Size, 2017-2028
6.5 Europe
  6.5.1 By Country - Europe Glatiramer Revenue, 2017-2028
  6.5.2 By Country - Europe Glatiramer Sales, 2017-2028
  6.5.3 Germany Glatiramer Market Size, 2017-2028
  6.5.4 France Glatiramer Market Size, 2017-2028
  6.5.5 U.K. Glatiramer Market Size, 2017-2028
  6.5.6 Italy Glatiramer Market Size, 2017-2028
  6.5.7 Russia Glatiramer Market Size, 2017-2028
  6.5.8 Nordic Countries Glatiramer Market Size, 2017-2028
  6.5.9 Benelux Glatiramer Market Size, 2017-2028
6.6 Asia
  6.6.1 By Region - Asia Glatiramer Revenue, 2017-2028
  6.6.2 By Region - Asia Glatiramer Sales, 2017-2028
  6.6.3 China Glatiramer Market Size, 2017-2028
  6.6.4 Japan Glatiramer Market Size, 2017-2028
  6.6.5 South Korea Glatiramer Market Size, 2017-2028
  6.6.6 Southeast Asia Glatiramer Market Size, 2017-2028
  6.6.7 India Glatiramer Market Size, 2017-2028
6.7 South America
  6.7.1 By Country - South America Glatiramer Revenue, 2017-2028
  6.7.2 By Country - South America Glatiramer Sales, 2017-2028
  6.7.3 Brazil Glatiramer Market Size, 2017-2028
  6.7.4 Argentina Glatiramer Market Size, 2017-2028
6.8 Middle East & Africa
  6.8.1 By Country - Middle East & Africa Glatiramer Revenue, 2017-2028
  6.8.2 By Country - Middle East & Africa Glatiramer Sales, 2017-2028
  6.8.3 Turkey Glatiramer Market Size, 2017-2028
  6.8.4 Israel Glatiramer Market Size, 2017-2028
  6.8.5 Saudi Arabia Glatiramer Market Size, 2017-2028
  6.8.6 UAE Glatiramer Market Size, 2017-2028

7 MANUFACTURERS & BRANDS PROFILES

7.1 Teva
  7.1.1 Teva Corporate Summary
  7.1.2 Teva Business Overview
  7.1.3 Teva Glatiramer Major Product Offerings
  7.1.4 Teva Glatiramer Sales and Revenue in Global (2017-2022)
  7.1.5 Teva Key News
7.2 NATCO Pharma
  7.2.1 NATCO Pharma Corporate Summary
  7.2.2 NATCO Pharma Business Overview
  7.2.3 NATCO Pharma Glatiramer Major Product Offerings
  7.2.4 NATCO Pharma Glatiramer Sales and Revenue in Global (2017-2022)
  7.2.5 NATCO Pharma Key News
7.3 Mylan
  7.3.1 Mylan Corporate Summary
  7.3.2 Mylan Business Overview
  7.3.3 Mylan Glatiramer Major Product Offerings
  7.3.4 Mylan Glatiramer Sales and Revenue in Global (2017-2022)
  7.3.5 Mylan Key News
7.4 Novartis
  7.4.1 Novartis Corporate Summary
  7.4.2 Novartis Business Overview
  7.4.3 Novartis Glatiramer Major Product Offerings
  7.4.4 Novartis Glatiramer Sales and Revenue in Global (2017-2022)
  7.4.5 Novartis Key News
7.5 HYBIO
  7.5.1 HYBIO Corporate Summary
  7.5.2 HYBIO Business Overview
  7.5.3 HYBIO Glatiramer Major Product Offerings
  7.5.4 HYBIO Glatiramer Sales and Revenue in Global (2017-2022)
  7.5.5 HYBIO Key News

8 GLOBAL GLATIRAMER PRODUCTION CAPACITY, ANALYSIS

8.1 Global Glatiramer Production Capacity, 2017-2028
8.2 Glatiramer Production Capacity of Key Manufacturers in Global Market
8.3 Global Glatiramer Production by Region

9 KEY MARKET TRENDS, OPPORTUNITY, DRIVERS AND RESTRAINTS

9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints

10 GLATIRAMER SUPPLY CHAIN ANALYSIS

10.1 Glatiramer Industry Value Chain
10.2 Glatiramer Upstream Market
10.3 Glatiramer Downstream and Clients
10.4 Marketing Channels Analysis
  10.4.1 Marketing Channels
  10.4.2 Glatiramer Distributors and Sales Agents in Global

11 CONCLUSION

12 APPENDIX

12.1 Note
12.2 Examples of Clients
12.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Key Players of Glatiramer in Global Market
Table 2. Top Glatiramer Players in Global Market, Ranking by Revenue (2021)
Table 3. Global Glatiramer Revenue by Companies, (US$, Mn), 2017-2022
Table 4. Global Glatiramer Revenue Share by Companies, 2017-2022
Table 5. Global Glatiramer Sales by Companies, (K Units), 2017-2022
Table 6. Global Glatiramer Sales Share by Companies, 2017-2022
Table 7. Key Manufacturers Glatiramer Price (2017-2022) & (USD/Unit)
Table 8. Global Manufacturers Glatiramer Product Type
Table 9. List of Global Tier 1 Glatiramer Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Glatiramer Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Glatiramer Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Global Glatiramer Revenue (US$, Mn), 2017-2022
Table 13. By Type - Global Glatiramer Revenue (US$, Mn), 2023-2028
Table 14. By Type - Global Glatiramer Sales (K Units), 2017-2022
Table 15. By Type - Global Glatiramer Sales (K Units), 2023-2028
Table 16. By Application – Global Glatiramer Revenue, (US$, Mn), 2021 & 2028
Table 17. By Application - Global Glatiramer Revenue (US$, Mn), 2017-2022
Table 18. By Application - Global Glatiramer Revenue (US$, Mn), 2023-2028
Table 19. By Application - Global Glatiramer Sales (K Units), 2017-2022
Table 20. By Application - Global Glatiramer Sales (K Units), 2023-2028
Table 21. By Region – Global Glatiramer Revenue, (US$, Mn), 2021 VS 2028
Table 22. By Region - Global Glatiramer Revenue (US$, Mn), 2017-2022
Table 23. By Region - Global Glatiramer Revenue (US$, Mn), 2023-2028
Table 24. By Region - Global Glatiramer Sales (K Units), 2017-2022
Table 25. By Region - Global Glatiramer Sales (K Units), 2023-2028
Table 26. By Country - North America Glatiramer Revenue, (US$, Mn), 2017-2022
Table 27. By Country - North America Glatiramer Revenue, (US$, Mn), 2023-2028
Table 28. By Country - North America Glatiramer Sales, (K Units), 2017-2022
Table 29. By Country - North America Glatiramer Sales, (K Units), 2023-2028
Table 30. By Country - Europe Glatiramer Revenue, (US$, Mn), 2017-2022
Table 31. By Country - Europe Glatiramer Revenue, (US$, Mn), 2023-2028
Table 32. By Country - Europe Glatiramer Sales, (K Units), 2017-2022
Table 33. By Country - Europe Glatiramer Sales, (K Units), 2023-2028
Table 34. By Region - Asia Glatiramer Revenue, (US$, Mn), 2017-2022
Table 35. By Region - Asia Glatiramer Revenue, (US$, Mn), 2023-2028
Table 36. By Region - Asia Glatiramer Sales, (K Units), 2017-2022
Table 37. By Region - Asia Glatiramer Sales, (K Units), 2023-2028
Table 38. By Country - South America Glatiramer Revenue, (US$, Mn), 2017-2022
Table 39. By Country - South America Glatiramer Revenue, (US$, Mn), 2023-2028
Table 40. By Country - South America Glatiramer Sales, (K Units), 2017-2022
Table 41. By Country - South America Glatiramer Sales, (K Units), 2023-2028
Table 42. By Country - Middle East & Africa Glatiramer Revenue, (US$, Mn), 2017-2022
Table 43. By Country - Middle East & Africa Glatiramer Revenue, (US$, Mn), 2023-2028
Table 44. By Country - Middle East & Africa Glatiramer Sales, (K Units), 2017-2022
Table 45. By Country - Middle East & Africa Glatiramer Sales, (K Units), 2023-2028
Table 46. Teva Corporate Summary
Table 47. Teva Glatiramer Product Offerings
Table 48. Teva Glatiramer Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 49. NATCO Pharma Corporate Summary
Table 50. NATCO Pharma Glatiramer Product Offerings
Table 51. NATCO Pharma Glatiramer Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 52. Mylan Corporate Summary
Table 53. Mylan Glatiramer Product Offerings
Table 54. Mylan Glatiramer Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 55. Novartis Corporate Summary
Table 56. Novartis Glatiramer Product Offerings
Table 57. Novartis Glatiramer Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 58. HYBIO Corporate Summary
Table 59. HYBIO Glatiramer Product Offerings
Table 60. HYBIO Glatiramer Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 61. Glatiramer Production Capacity (K Units) of Key Manufacturers in Global Market, 2020-2022 (K Units)
Table 62. Global Glatiramer Capacity Market Share of Key Manufacturers, 2020-2022
Table 63. Global Glatiramer Production by Region, 2017-2022 (K Units)
Table 64. Global Glatiramer Production by Region, 2023-2028 (K Units)
Table 65. Glatiramer Market Opportunities & Trends in Global Market
Table 66. Glatiramer Market Drivers in Global Market
Table 67. Glatiramer Market Restraints in Global Market
Table 68. Glatiramer Raw Materials
Table 69. Glatiramer Raw Materials Suppliers in Global Market
Table 70. Typical Glatiramer Downstream
Table 71. Glatiramer Downstream Clients in Global Market
Table 72. Glatiramer Distributors and Sales Agents in Global Market

List Of Figures

LIST OF FIGURES

Figure 1. Glatiramer Segment by Type
Figure 2. Glatiramer Segment by Application
Figure 3. Global Glatiramer Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Glatiramer Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Glatiramer Revenue, 2017-2028 (US$, Mn)
Figure 7. Glatiramer Sales in Global Market: 2017-2028 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Glatiramer Revenue in 2021
Figure 9. By Type - Global Glatiramer Sales Market Share, 2017-2028
Figure 10. By Type - Global Glatiramer Revenue Market Share, 2017-2028
Figure 11. By Type - Global Glatiramer Price (USD/Unit), 2017-2028
Figure 12. By Application - Global Glatiramer Sales Market Share, 2017-2028
Figure 13. By Application - Global Glatiramer Revenue Market Share, 2017-2028
Figure 14. By Application - Global Glatiramer Price (USD/Unit), 2017-2028
Figure 15. By Region - Global Glatiramer Sales Market Share, 2017-2028
Figure 16. By Region - Global Glatiramer Revenue Market Share, 2017-2028
Figure 17. By Country - North America Glatiramer Revenue Market Share, 2017-2028
Figure 18. By Country - North America Glatiramer Sales Market Share, 2017-2028
Figure 19. US Glatiramer Revenue, (US$, Mn), 2017-2028
Figure 20. Canada Glatiramer Revenue, (US$, Mn), 2017-2028
Figure 21. Mexico Glatiramer Revenue, (US$, Mn), 2017-2028
Figure 22. By Country - Europe Glatiramer Revenue Market Share, 2017-2028
Figure 23. By Country - Europe Glatiramer Sales Market Share, 2017-2028
Figure 24. Germany Glatiramer Revenue, (US$, Mn), 2017-2028
Figure 25. France Glatiramer Revenue, (US$, Mn), 2017-2028
Figure 26. U.K. Glatiramer Revenue, (US$, Mn), 2017-2028
Figure 27. Italy Glatiramer Revenue, (US$, Mn), 2017-2028
Figure 28. Russia Glatiramer Revenue, (US$, Mn), 2017-2028
Figure 29. Nordic Countries Glatiramer Revenue, (US$, Mn), 2017-2028
Figure 30. Benelux Glatiramer Revenue, (US$, Mn), 2017-2028
Figure 31. By Region - Asia Glatiramer Revenue Market Share, 2017-2028
Figure 32. By Region - Asia Glatiramer Sales Market Share, 2017-2028
Figure 33. China Glatiramer Revenue, (US$, Mn), 2017-2028
Figure 34. Japan Glatiramer Revenue, (US$, Mn), 2017-2028
Figure 35. South Korea Glatiramer Revenue, (US$, Mn), 2017-2028
Figure 36. Southeast Asia Glatiramer Revenue, (US$, Mn), 2017-2028
Figure 37. India Glatiramer Revenue, (US$, Mn), 2017-2028
Figure 38. By Country - South America Glatiramer Revenue Market Share, 2017-2028
Figure 39. By Country - South America Glatiramer Sales Market Share, 2017-2028
Figure 40. Brazil Glatiramer Revenue, (US$, Mn), 2017-2028
Figure 41. Argentina Glatiramer Revenue, (US$, Mn), 2017-2028
Figure 42. By Country - Middle East & Africa Glatiramer Revenue Market Share, 2017-2028
Figure 43. By Country - Middle East & Africa Glatiramer Sales Market Share, 2017-2028
Figure 44. Turkey Glatiramer Revenue, (US$, Mn), 2017-2028
Figure 45. Israel Glatiramer Revenue, (US$, Mn), 2017-2028
Figure 46. Saudi Arabia Glatiramer Revenue, (US$, Mn), 2017-2028
Figure 47. UAE Glatiramer Revenue, (US$, Mn), 2017-2028
Figure 48. Global Glatiramer Production Capacity (K Units), 2017-2028
Figure 49. The Percentage of Production Glatiramer by Region, 2021 VS 2028
Figure 50. Glatiramer Industry Value Chain
Figure 51. Marketing Channels